FDA has removed the ICLUSIG REMS information from its website, and the ICLUSIG REMS website was deactivated by Takeda at the end of July. Takeda will continue to educate patients and physicians about the risks associated with ICLUSIG.
FDA Discontinues Iclusig® REMS Program
- August 1, 2018
- No responses